Browse Categories
| Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer |
 |
 |
Last Updated ( Mon, 01 June 2009 )
Login to read more...| Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients |
|
|
Last Updated ( Mon, 01 June 2009 )
Login to read more...| Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients |
|
|
Last Updated ( Mon, 01 June 2009 )
Login to read more...| Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting |
|
|
Last Updated ( Mon, 01 June 2009 )
Login to read more...| PROSTVAC™ Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer |
|
|
Last Updated ( Mon, 01 June 2009 )
Login to read more...| Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO |
|
|
Last Updated ( Mon, 01 June 2009 )
Login to read more...| Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology |
|
|
Last Updated ( Fri, 29 May 2009 )
Login to read more...| OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting |
|
|
Last Updated ( Mon, 01 June 2009 )
Login to read more...| Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009 |
|
|
Last Updated ( Fri, 29 May 2009 )
Login to read more...| Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting |
|
|
Last Updated ( Fri, 29 May 2009 )
Login to read more...